The PSCI - Pharmaceutical Supply Chain Initiative is committed to fostering a vision of excellence in safety, environmental, and social outcomes across global communities. Through its knowledge-driven conferences, PSCI continues to shape the future of sustainability and collaboration in the pharmaceutical supply chain.?? ? This November, PSCI hosted its Fall Meeting (6–7 Nov 2024) in Germany, graciously hosted by Boehringer Ingelheim. The event brought together industry leaders, including the PSCI India Team and members from across the globe.?? ? We are proud to share that Aurobindo Pharma, a full member of PSCI, actively participated in the event, and was represented by Dr. JVN Reddy (Director, Advisor – EHS).?? ? Key highlights of the meeting included:?? - Supplier Engagement?? - Decarbonisation?? - PSCI Modular Audit Framework and Projects?? - Global Supplier Conference? - Panel Discussions & Workshops?? ? At Aurobindo Pharma, we remain committed to advancing sustainable and ethical practices that align with PSCI’s vision for a better tomorrow.?? ? #PSCI2024 #SustainabilityInPharma #AurobindoPharma #GlobalCollaboration #Decarbonisation #SupplierEngagement
关于我们
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. The company has 25 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The company’s robust product portfolio is spread over 7 major therapeutic/product areas encompassing CNS, Antiretroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.
- 网站
-
https://www.aurobindo.com/
AUROBINDO PHARMA LTD的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Hyderabad,Telangana
- 类型
- 上市公司
- 创立
- 1986
- 领域
- API、Formulation、R&D、Enzymes、Vaccine、Biologics、Generics、Specialty、Injectables和Oncology
地点
-
主要
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,
IN,Telangana,Hyderabad,500032
AUROBINDO PHARMA LTD员工
-
Chitti Babu
-
Yavor Slavov
Business Development Manager-Central & Eastern Europe at Aurobindo Pharma Ltd
-
Praveen Kumar
General Manager Packaging Development at Aurobindo Pharma Limited
-
Vinod Krishnan
Head | Associate Vice President - Learning Leadership Culture & Centre of Excellence, Human Resources
动态
-
Eugia Pharma Specialities Ltd is Hiring Quality Assurance Professionals! If you have the expertise and passion for quality assurance, we want to hear from you! Quality starts with you. Join us and make a difference! #Hiring #PharmaJobs #Pharmajobopenings #AurobindoPharmaLimited
?? Ignite Your Career with Eugia Pharma! We are hiring for Quality Assurance professionals! ?? Send your CV to: 1. SHWETABH SINGH at [email protected] 2. Anil Kumar Singh at [email protected] Harika Namburi AUROBINDO PHARMA LTD
-
Aurobindo Pharma arm inks $25-million licence deal with global player. Click the link to know more: https://lnkd.in/gYumi6X4
-
We are delighted to announce that Aurobindo Pharma Limited, Unit III has successfully received Regulatory Approval from the Eurasian Economic Union (EAEU) Pharmaceutical Inspectorate, Ministry of Industry and Trade of the Russian Federation.? This significant milestone follows the GMP Inspection conducted from 17th to 20th June 2024 by esteemed inspectors, Mr. Vladimir Igorevich Pavlov and Mr. Artem Vladimirovich Yakovlev.?? ? The Approval/Registration Certificate was personally handed over by Mr. Deepak Singh, Country Head, Russia, and Ms. Olesya Morozova, Senior Manager, Regulatory Affairs, Russia, to:?? Dr. A R M Rao, Quality Officer, Global Quality?? Mr. Malineni Venkateswar Rao, Senior Vice President - Quality, Unit III?? Mr. Kamaraj Abraham, Associate Vice President - QA, Unit III?? Mr. Madhu Mvv, Senior Scientist, Regulatory Affairs, India?? ? This achievement reflects our unwavering commitment to quality and compliance on a global scale.?? ? #AurobindoPharma #QualityExcellence #GMPApproval #GlobalStandards
-
Eugia Pharma Specialities Limited – a wholly owned subsidiary of AUROBINDO PHARMA LTD – is steadfast in its mission to deliver high-quality generic sterile injectables, oncology, hormonal, and ophthalmic medicines. We are proud to have a strong presence in the USA, with expanding footprints across Europe and several emerging markets. Recently, Eugia marked another milestone by launching three oncology products in Australia, with many more products in the pipeline for approval over the next 12 months. Our Eugia Australia team actively participated in the Medicines Management 2024 Conference at the Adelaide Convention Center, hosted by Advanced Pharmacy Australia. This impactful event, held from November 14-16, brought together pharmacy professionals to discuss advancements and innovation in the industry. Yugandhar Puvvala Vijay Natarajan Abhishek Khadria Vyas Sandip #EugiaPharma #Pharmaceuticals #Oncology #Innovation #MedicinesManagement2024 #Australia
-
Aurobindo Pharma is dedicated to providing a supportive work culture and growth opportunities to employees. Dr UNB Raju Sr Vice President – HR, emphasizes the company's dedication to continuous training and skill development, stressing the importance of regularly upgrading employees' skills to remain competitive in an ever-changing industry. Click to listen to his perspective and the company's upcoming learning and development initiatives. #LifeAtAuro #AurobindoPharmaLtd #EmployeeSpotlight #Testimonials #Lifeinpharma
-
Aurobindo Pharma's subsidiary CuraTeQ Biologics has received a GMP certificate of compliance for its biosimilars manufacturing facility from the European Medicines Agency (EMA). Click to read the full article: https://lnkd.in/g77kBhka #PenicillinG #LyfiusPharma #AtmanirbharBharat #HealthcareInnovation #MadeInIndia
Aurobindo arm CuraTeQ Biologics gets GMP certificate from EMA?
thehindu.com
-
Aurobindo Pharma Q2 net profit rises 9%. Read more about our Q2 FY25 results: https://lnkd.in/g2KyF_HW
Aurobindo Pharma Q2 net profit rises 9% - Times of India
timesofindia.indiatimes.com
-
Dr. Vijayapal Reddy KanumathiReddy, Associate Vice President of Strategic Purchase at Aurobindo, has developed a well-rounded perspective by working on critical projects throughout his tenure. He credits Aurobindo’s collaborative culture and commitment to excellence for his continued growth and success. Tune in to hear directly from Dr.?Vijaypal?about his experiences and what Life@Auro looks like! #LifeAtAuro #AurobindoPharmaLtd #EmployeeSpotlight #Testimonials #Lifeinpharma
-
At Aurobindo Pharma, Diwali was as bright as ever! From vibrant rangoli creations and captivating dance performances to heartfelt singing and candle lighting, our office lit up with warmth and festive cheer. Here’s to cherishing these moments of togetherness as we continue to foster a sense of community and positivity in our workplace. Wishing everyone a joyous Diwali! #Diwali #DiwaliAtAuro
-
+9